Skip to main content
GutCited
2.3. Study Design and Product
Figure 2. 2.3. Study Design and Product

Description

Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.

More Figures from This Paper

Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.

Figure 3

Gastrointestinal symptom scores at baseline and follow-up are compared between the postbiotic HT-ES1 and placebo groups, showing changes in digestive comfort over the intervention period.

chart
Individual gastrointestinal symptom subscores including bloating, abdominal pain, and flatulence are presented for postbiotic and placebo groups across the study timepoints.

Figure 4

Individual gastrointestinal symptom subscores including bloating, abdominal pain, and flatulence are presented for postbiotic and placebo groups across the study timepoints.

chart

Figure 2

Diagram
598 × 664px · 103,5 Kio

Source Paper

Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, …

Nutrients (2024)

PMID: 39599737

DOI: 10.3390/nu16223952

Cite This Figure

![Figure 2: Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.](https://pdfs.citedhealth.com/figures/39599737/166.png)

> Source: Malwina Naghibi et al. "Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Sympto." *Nutrients*, 2024. PMID: [39599737](https://pubmed.ncbi.nlm.nih.gov/39599737/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39599737/166.png" alt="Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial." />
  <figcaption>Figure 2. Study product composition and dosing protocol for heat-treated Bifidobacterium longum CECT 7347 are described, detailing the intervention design for this gastrointestinal symptom trial.<br>  Source: Malwina Naghibi et al. "Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Sympto." <em>Nutrients</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39599737/">39599737</a></figcaption>
</figure>

Preuves associées

B
Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)

Note B · 4 études